Loading…
Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens
Detecting the entire repertoire of tumor-specific reactive tumor-infiltrating lymphocytes (TILs) is essential for investigating their immunological functions in the tumor microenvironment. Current assays identifying tumor-specific functional activation measure the upregulation of surface molecules,...
Saved in:
Published in: | Frontiers in immunology 2021-10, Vol.12, p.705422-705422 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Detecting the entire repertoire of tumor-specific reactive tumor-infiltrating lymphocytes (TILs) is essential for investigating their immunological functions in the tumor microenvironment. Current
assays identifying tumor-specific functional activation measure the upregulation of surface molecules,
production of antitumor cytokines, or mobilization of cytotoxic granules following recognition of tumor-antigens, yet there is no widely adopted standard method. Here we established an enhanced, yet simple, method for identifying simultaneously CD8
and CD4
tumor-specific reactive TILs
, using a combination of widely known and available flow cytometry assays. By combining the detection of intracellular CD137 and
production of TNF and IFNγ after recognition of naturally-presented tumor antigens, we demonstrate that a larger fraction of tumor-specific and reactive CD8
TILs can be detected
compared to commonly used assays. This assay revealed multiple polyfunctionality-based clusters of both CD4
and CD8
tumor-specific reactive TILs.
, the combined detection of
,
, and
identified most of the tumor-specific reactive TIL repertoire. In conclusion, we describe a straightforward method for efficient identification of the tumor-specific reactive TIL repertoire
, which can be rapidly adopted in most cancer immunology laboratories. |
---|---|
ISSN: | 1664-3224 1664-3224 |
DOI: | 10.3389/fimmu.2021.705422 |